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Polyhydroxyalkanoates (PHAs) are polyesters of 3-hydroxyalkanoic acids that are produced as intracellular granules by many different bacteria (29) . Bacterial PHA polymers have generated research interest because of their potential use as biodegradable thermoplastics and elastomers; however, the high cost of their production has limited their widespread use (18, 30) . Currently, researchers are investigating alternative strategies for PHA production in order to reduce production costs. One way of reducing the costs of PHA production is to use inexpensive growth substrates, such as sugars, and to use recombinant strains of bacteria, such as Escherichia coli, to increase the PHA yield (18, 30) .
PHAs produced by bacteria consist of three main types: polymers composed of short-chain-length (SCL) monomers, polymers composed of medium-chain-length (MCL) monomers, and polymers composed of SCL-MCL monomers. SCL PHA consists of monomeric subunits 3 to 5 carbons in length, while MCL PHA consists of monomers 6 to 14 carbons in length and SCL-MCL PHA copolymer consists of monomeric subunits 4 to 12 carbons in length. These differences in PHA monomer composition can dramatically affect the properties and qualities of the polymers. SCL PHA homopolymers, such as poly-3-hydroxybutyrate [P(3HB)], form a stiff crystalline material, which leads to brittleness and low extension to break. This lack of flexibility limits its range of applications. Polymers consisting of only MCL PHA are semicrystalline thermoplastic elastomers, which may have their mechanical properties enhanced by reinforcement with nanocomposite materials and fillers (6) (7) (8) . However, unlike polymers composed solely of either SCL or MCL monomer units, SCL-MCL PHA copolymers can have a wide range of physical properties, depending on the mole percent composition of the different monomers incorporated into the polymer. SCL-MCL PHA copolymers with low moles percent of SCL monomer units are more elastomeric in nature, while SCL-MCL PHA copolymers, such as a copolymer made of a high mole percent of 3HB and a low mole percent of (R)-3-hydroxyhexanoate (3HHx), have been demonstrated to be flexible materials with properties similar to those of polypropylene (20) . Because of the potentially wide range of applications for SCL-MCL PHA copolymer, it is desirable to identify methods and metabolic pathways that enable bacteria to produce it.
Although the production of MCL PHA has been successfully accomplished using recombinant E. coli, the carbon source for such strains is usually limited to fatty acid or related carbon substrate precursors, such as decanoate and dodecanoate (14, 17, 22) . Production of MCL PHA from unrelated carbon sources has proved more difficult to accomplish in E. coli, and there are few studies available in which MCL PHA was produced from unrelated carbon sources (15, 25, 26) . Two very similar methods utilized the coexpression of either the E. coli tesA gene, encoding a modified E. coli thioesterase, with the PHA synthase gene (phaC1) from Pseudomonas oleovorans (15) or the Umbellularia californica thioesterase gene and PHA synthase (26) in E. coli grown in the presence of gluconate to accumulate MCL PHA. Coexpression of the E. coli tesA gene and the Pseudomonas oleovorans phaC1 gene led to the accumulation of MCL PHA copolymer composed of C 6 , C 8 , and C 10 monomers (15) . Coexpression of the U. californica thioesterase gene with the Ralstonia eutropha phaC gene and the Pseudomonas aeruginosa phaC1 gene led to the accumulation of either P(3HB) homopolymer or poly-3-hydroxydecanoate homopolymer, respectively (26) . A third method for accumulating MCL PHA from unrelated carbon sources in E. coli was by coexpression of the Pseudomonas putida phaG gene, encoding a putative transacylase and PHA synthase, and the P. aeruginosa phaC1 gene in the presence of the enoyl-ACP reductase inhibitor triclosan, which led to the accumulation of 2 to 3% (cellular dry weight) poly-3-hydroxydecanoate homopolymer (25) . Although these previous reports describe MCL PHA production from unrelated carbon sources in E. coli, there have been no reports regarding the production of SCL-MCL PHA copolymer from unrelated carbon sources in recombinant E. coli.
It was previously shown that coexpression of the PHA synthase gene (phaC) from Aeromonas caviae and the 3-ketoacylacyl carrier protein synthase (ACP) III gene (fabH) from E. coli led to the production of P(3HB) in recombinant E. coli grown in the presence of glucose (32) . Although these cells were shown to produce P(3HB) homopolymer consisting only of 3HB monomers, this study demonstrated the link between fatty acid biosynthesis and PHA production in recombinant E. coli (32) .
The FabH protein, or 3-ketoacyl-ACP synthase III, is a member of the ␤-ketoacyl synthase family of enzymes (5) . The primary reaction of the FabH enzyme is the condensation of malonyl-ACP with acetyl-coenzyme A (CoA). It is unique among ␤-ketoacyl synthase enzymes in that it utilizes acetylCoA as a donor and has been shown to have an acetyl-CoA-ACP transacylase activity in vitro (33) . Despite the overall similarities in their primary amino acid sequences, the FabH proteins from various bacterial species have been shown to have very different substrate specificities (3, 4, 13) . For example, the E. coli FabH protein has specificity for carbon substrates 2 to 4 carbons in length, while the Mycobacterium tuberculosis FabH protein displays specificity for carbon substrates 10 to 16 carbons in length in vitro (4) . The crystal structures of both the E. coli FabH protein (5, 23, 24) and the M. tuberculosis FabH (28) protein have been determined, and comparison of the primary amino acid sequences and the two crystal structures revealed a potential explanation for the difference in substrate specificity observed between the E. coli FabH and the M. tuberculosis FabH. In the E. coli FabH protein, there is a Phe residue at position 87. This amino acid occupies the end of the predicted substrate-binding pocket and obstructs the binding of straight fatty acid chains longer than four carbons. On the other hand, a Thr residue occupies position 87 in the M. tuberculosis FabH protein, and this enzyme displays specificity for substrates of C 8 to C 16 lengths (4). The smaller size of Thr87 compared to Phe87 may allow the binding of longer-chain fatty acids and thus produce the observed difference in substrate specificity between the two proteins (28).
These differences in substrate binding specificity may have an effect on the PHA monomer supply in E. coli, and it was hypothesized that if the E. coli FabH protein had an amino acid residue other than Phe, it would be able to recognize substrates larger than four carbons and subsequently produce MCL 3-hydroxyacyl (3HA) monomers for incorporation into a growing PHA polymer. In order to address whether Phe87 of E. coli FabH affects the substrate specificity and monomer supply for PHA, saturation site-directed mutagenesis was performed on the codon encoding Phe87. A series of amino acid substitution mutant expression plasmids were constructed and individually cotransformed into E. coli with the expression plasmids harboring PHA synthase genes from either A. caviae (9) or Pseudomonas sp. strain 61-3 (21) . The isolated transformants were assayed for the ability to produce MCL PHA copolymer from glucose. Several recombinant E. coli strains harboring a mutant fabH gene coexpressed with phaC were able to accumulate unusual PHA copolymers containing SCL (C 4 ) and MCL (C 6 to C 10 ) monomer units, suggesting that the substrate specificity of FabH could be modified on a molecular level and that this specificity is an important regulator of the monomer type incorporated into PHA polymers. Furthermore, this study represents the first report of the production of SCL-MCL PHA copolymers in E. coli grown in the presence of an unrelated carbon source.
MATERIALS AND METHODS
Bacterial strains, plasmids, and cultivation conditions. All transformations and experiments were carried out using E. coli JM109 {recA1 endA1 gyrA96 thi-1 hsdR17
]} (Takara, Tokyo, Japan) as a host strain, and all strains were grown at 30°C in LuriaBertani (LB) medium supplemented with glucose to a final concentration of 2 mg ml Ϫ1 as a carbon source where appropriate. One hundred micrograms of ampicillin and/or 50 g of kanamycin was used for plasmid selection in recombinant E. coli strains as appropriate. The plasmids used in this study are listed in Table  1 .
Isolation, analysis, and manipulation of DNA. The DNA sequences of plasmid constructs were confirmed by dye termination cycle sequencing using a Beckman-Coulter CEQ 2000 sequencer. All other genetic techniques were performed as previously described (27) .
Cloning of the E. coli fabH gene. The E. coli fabH gene was amplified from E. coli genomic DNA by PCR with the following primers: for the 5Ј end, 5Ј-GT GAC TGA GCG TAC ATG TAT ACG AAG-3Ј, where boldface lettering indicates an AflIII site engineered into the primer, and for the 3Ј end, 5Ј-GAG GAT CCC TAG AAA CGA ACC AGC GCG GAG C-3Ј, where boldface lettering indicates a BamHI site engineered into the primer. The fabH PCR product was digested with AflIII and BamHI and ligated into the NcoI and BamHI sites of the expression plasmid pTrc99A (Amersham Pharmacia). The resulting plasmid was named pTrcFabH, and the insertion of the fabH gene was confirmed by digestion with restriction enzymes and DNA sequencing.
Saturation point mutagenesis of Phe87 in the E. coli fabH gene. Primers with point mutations in the codon encoding the amino acid at position 87 were made as indicated in Table 2 and were used to amplify the entire pTrcFabH plasmid by PCR using the 3Ј-5Ј proofreading enzyme PfxI (Invitrogen). The resultant PCR products were self-ligated and transformed into competent E. coli JM109 cells. Transformants were isolated, and the individual plasmids were sequenced to confirm the insertion of the desired point mutation in the fabH gene. To confirm that no other point mutations had occurred in regions that could affect the copy number or transcription of the mutant fabH genes, the corresponding nucleotide sequences for the promoter, LacI q binding site, lacI q promoter, lacI q gene, and origin of replication were sequenced on each plasmid. No mutations were found in these regions (data not shown).
PHA production from glucose in recombinant E. coli. Confirmed plasmids harboring wild-type or mutant fabH genes were cotransformed with either pAPAC or pPPAC into E. coli JM109 cells. Transformants were isolated, and the presence of both the pTrcFabH plasmid and either the pAPAC or pPPAC plasmid was confirmed by restriction digestion and PCR. Single colonies of confirmed transformants were cultured overnight in 1.75 ml of LB medium and used to inoculate 500-ml culture flasks with 100 ml of LB medium. Cultures were incubated at 30°C and constantly shaken at 150 rpm for 9 h, at which time expression of the fabH and phaC genes was induced by the addition of 1 mM IPTG (isopropyl-␤-D-thiogalactopyranoside). The cultures were grown for an additional 3 h, at which time glucose was added to a final concentration of 2 g ml Ϫ1 . The cells were allowed to grow for an additional 12 h after glucose addition before being harvested by centrifugation. The PHA contents were determined by gas chromatography (GC) analysis of lyophilized cells GC analysis of PHA compositions. The PHA contents and PHA compositions were determined by GC analysis. Liquid cultures (100 ml) were centrifuged at 5,000 ϫ g for 10 min at 4°C, and the cells were washed twice with ice-cold Milli-Q double-distilled water and lyophilized for a minimum of 48 h. The lyophilized cell After cooling to room temperature, the watersoluble contents were removed by the addition of 1 ml of sterile double-distilled water and vigorous mixing of the samples by vortexing for 30 s. The aqueous and organic phases were allowed to separate, and the organic phase containing the chloroform-soluble methyl esters was removed with a Pasteur pipette and filtered through a 0.45-m-pore-size Millex polytetrafluorethylene (PTFE) LCR membrane (Millipore) for each sample. A total of 500 l of the organic-phase mixture containing the soluble methyl esters and 500 l of 0.1% (wt/vol) caprillic acid in methanol were mixed in GC tubes, and these samples were assayed as described previously using a GC17A gas chromatograph with a 30-m column (Shimadzu, Kyoto, Japan) (12) . GPC analysis of PHA polymers. Cell materials for gel permeation chromatography (GPC) analysis were prepared and lyophilized as described for GC analysis except that a total of 2 liters of liquid culture per sample was harvested by centrifugation. The lyophilized cells were added to 100 ml of chloroform and stirred in a covered beaker at room temperature for 48 h to extract the polymers. The chloroform-polymer solution was filtered, first through filter paper to remove cell debris and then through a 0.45-m-pore-size PTFE membrane to remove any residual solid materials. The chloroform was evaporated using a rotary vacuum evaporator (Eyela, Tokyo, Japan), and the isolated polymer was washed with 20 ml of hexane. The polymer was allowed to dry at room temperature and was redissolved in 20 ml of chloroform. The polymer was precipitated by the addition of a 10ϫ volume of hexane and collected by filtering the solution through a 0.45-m-pore-size PTFE membrane. The membrane and polymers were allowed to dry at room temperature, and the polymers were dissolved by the addition of chloroform and collected in a beaker. The chloroform was allowed to evaporate at room temperature in a fume hood for 48 h, and the polymer cast film was weighed and used for GPC analysis. Molecular mass data for polyesters were obtained by GPC analysis using a Shimadzu 10A system with a RID-10A refractive-index detector with serial columns of ShodexK802 and K806 M, as described previously (16) .
RESULTS
Effect of coexpression of point mutant E. coli fabH and A. caviae phaC genes on PHA production in recombinant E. coli. To address whether modification of the substrate-binding pocket of E. coli FabH could alter the substrate specificity and monomer supply for PHA production in E. coli, saturation point mutagenesis was done, in which 19 individual point mutations corresponding to all other amino acids were introduced to the codon encoding amino acid 87 of the E. coli fabH gene, as shown in Table 2 . The individual mutant pTrcFabH plasmids were cotransformed with pAPAC, which carries the A. caviae phaC gene. The PHA accumulation results are summarized in Table 3 . As was previously shown, coexpression of the wild-type fabH gene with A. caviae phaC led to the production of P(3HB) homopolymer composed of C 4 monomers as determined by GC, with a maximum PHA content of 9.8% (cell dry weight). In addition to the E. coli strain coexpressing the wildtype fabH and A. caviae phaC genes, the following 11 fabH mutations were capable of supplying monomers for PHA production: F87W, F87T, F87L, F87S, F87Y, F87C, F87V, F87I, F87A, F87 M, and F87N (Table 3) .
All of the fabH mutant strains capable of producing PHA had total PHA contents lower than the PHA accumulated in an E. coli strain with pTrcFabH and pAPAC (Table 3) . Coexpression of three of the mutant fabH genes, F87W, F87V, and F87Q, with the A. caviae phaC gene accumulated P(3HB) composed solely of C 4 monomers, in addition to a strain harboring pTrcFabH and pAPAC. However, strains harboring expression plasmids with the eight mutations F87T, F87L, F87S, F87Y, F87C, F87I, F87A, and F87M were able to accumulate SCL-MCL PHA copolymers consisting of various percentages of C 4 and C 6 monomers (Table 3) . A control strain of E. coli harboring only the pAPAC expression plasmid failed to accumulate PHA. These results suggest that the coexpression of the fabH genes and A. caviae phaC is essential for PHA production and that overexpression of the fabH genes was necessary for the supply of monomers for PHA production; strains expressing the genomic copy of fabH alone with the A. caviae phaC gene were unable to accumulate detectable levels of PHA. E. coli strains harboring plasmids expressing A. caviae phaC and the mutation F87N, F87K, F87P, F87D, F87E , F87H, F87G, or F87R in the fabH gene also failed to accumulate PHA. These results suggest that the F87N, F87K, F87P,  F87D, F87E, F87H, F87G , and F87R mutations inactivate the ability of the FabH protein to act as a monomer supplier for PHA synthesis.
Effect of coexpression of point mutant E. coli fabH and Pseudomonas sp. strain 61-3 phaC1 genes on PHA production in recombinant E. coli. Although the coexpression of the mutant E. coli fabH genes and A. caviae phaC led to the production of SCL-MCL PHA, this copolymer was composed solely of 3HB and 3HHx monomers. The observed result may have been influenced by the fact that the A. caviae PHA synthase displays strong substrate specificities for C 4 and C 6 monomer units (9) . It was unknown whether any of the mutant FabH proteins were capable of generating monomers longer than C 6 for PHA production. In order to investigate whether the ex- pTrcFabH (WT fabH) 1.1 Ϯ 0.5 9.8 Ϯ 1.9 100 0 pTrcFabH(F87W) e Only the pAPAC plasmid was harbored in this strain.
pression of the mutant E. coli fabH genes could produce monomers other than 3HB and 3HHx for PHA production, the pTrcFabH plasmids were cotransformed into E. coli JM109 with pPPAC. pPPAC is an expression plasmid harboring the Pseudomonas sp. strain 61-3 phaC1 gene (31) . Previous studies showed that the Pseudomonas sp. strain 61-3 PhaC1 protein was able to produce SCL-MCL PHA copolymers with substrate specificity for monomers consisting of C 4 to C 12 (21) . Table 4 shows the results of PHA production in E. coli strains transformed with the pTrcFabH plasmids with pPPAC. The results indicate that even the wild-type fabH gene coexpressed with pPPAC was able to accumulate a PHA copolymer composed of C 4 and C 6 monomers ( Table 4 ). The coexpression of Pseudomonas sp. strain 61-3 phaC1 and specific mutant E. coli fabH genes resulted in the production of SCL-MCL PHA copolymers consisting of monomers of C 4 to C 10 as shown in Table 4 . All of the pTrcFabH/pPPAC strains accumulated less total polymer than the corresponding pTrcFabH/pAPAC strains. However, the abilities of individual strains to accumulate PHA were similar, and most of the strains harboring fabH mutant genes that were able to accumulate PHA with pAPAC were also able to accumulate PHA if cotransformed with pPPAC. The strains harboring fabH genes with the eight mu- tations F87N, F87K, F87P, F87D, F87E, F87H , F87G, and F87R with pPPAC also failed to provide monomers for PHA production when cotransformed with either pAPAC or pPPAC (Tables 3 and 4) . A control strain of E. coli harboring only pPPAC also failed to accumulate any detectable amounts of PHA, as was the case with an E. coli strain harboring only the pAPAC plasmid. These results indicate that the overexpression of some of the mutant fabH genes enabled the recombinant E. coli to supply monomers ranging in size from C 4 to C 10 for PHA production. The results also imply that some mutations have a deleterious effect on the function of the FabH enzyme.
Physical characteristics of PHA isolated from recombinant E. coli strains. The results indicated that coexpression of a wild-type copy of fabH and A. caviae phaC led to the highest accumulation of PHA, whereas a combination of an E. coli fabH gene harboring a Phe873Cys87 mutation coexpressed with the A. caviae phaC gene had the highest content of C 6 monomer (3HHx) ( Table 3) . Because of the relatively high yield of polymers from these strains, further experiments were carried out to isolate and characterize the physical properties of the polymers produced. The PHA polymers were isolated from a strain of E. coli harboring pTrcFabH and pAPAC, as (Table 5 ). The numberaverage molecular weight (M n ), weight-average molecular weight (M w ), and polydispersity (M w /M n ) are similar for the two different polymer isolates. The M n and M w are comparable to those of other bacterially produced PHA polymers; however, the polydispersity index is slightly larger than that of other bacterial-polymer isolates (20) . This is due to the broad distribution of the molecular masses, which were found to be 9.3 ϫ 10 3 to 1.4 ϫ 10 7 Da for the polymer isolated from cells harboring pTrcFabH and pAPAC and 1.2 ϫ10 4 to 1.8 ϫ 10 7 Da for polymer isolated from cells harboring pTrcFabH(F87C) and pAPAC.
DISCUSSION
Unlike petroleum-based plastics, PHAs are environmentally friendly, biodegradable polymers, since they can be easily mineralized to CO 2 and H 2 O (30). P(3HB) homopolymer can be produced in many bacterial strains, but it is a highly crystalline, stiff material that is brittle and has limited applications. However, the SCL-MCL PHA copolymers composed of 3HB units with a small amount of 3HA units of C 6 to C 12 have been demonstrated to be more flexible materials than P(3HB) and thus have better mechanical properties (1, 20) , whereas, copolymers consisting solely of MCL PHA are elastomers whose applications may be enhanced by the addition of nanocomposite materials (6, 7) . It is likely that SCL-MCL PHA copolymers consisting of low moles percent of 3HA units would have physical characteristics similar to those of MCL PHA copolymers.
In order to develop a metabolic pathway to supply monomers for SCL-MCL PHA copolymer production, we evaluated the effect of saturation site-directed mutagenesis of the codon for Phe87 in the E. coli fabH gene on monomer supply for PHA production in recombinant E. coli. The data presented here show that coexpression of E. coli fabH genes with mutations in the codon for Phe87 with either A. caviae phaC or Pseudomonas sp. strain 61-3 phaC1 in recombinant E. coli led to the production of SCL-MCL PHA copolymers from glucose. Moreover, these point mutations had dramatic effects on the monomer compositions of the polymers (Tables 3 and 4) , which may lead to differences in the physical properties of each polymer.
Based on the results of this study, FabH likely acts as an intermediary for one or more PHA monomer (R)-3-hydroxyacyl-CoA-supplying pathways in E. coli originating from fatty acid biosynthesis (Fig. 1) . The distribution in the mole percent of the specific monomers is likely to be dependent on several factors. One factor is the substrate specificity of the FabH enzyme. Because the E. coli wild-type FabH has substrate specificity for two-to four-carbon substrates, its overproduction likely led to the accumulation of acetoacetyl-CoA via a transacylase reaction (Fig. 1, reaction 3) , which was converted to (R)-3-hydroxybutyrl-CoA by ␤-ketoacyl-ACP reductase (FabG) (31) . Subsequently, (R)-3-hydroxybutyrl-CoA could be incorporated into P(3HB) via the PHA synthase (PhaC) (Fig.  1, reaction 5) . However, expression of a fabH gene with a mutation in the codon encoding amino acid 87 produced an enzyme capable of interacting with substrates of C 4 to C 10 . The modified enzymes would likely be able to recognize both acetoacetyl-ACP and 3-ketoacyl-ACP as substrates, converting them into the equivalent CoA forms, which are then converted to the (R)-3-hydroxyacyl-CoA substrates by FabG (Fig. 1, reactions 3 and 4) . These substrates are then incorporated into the SCL-MCL PHA copolymer P(3HB-co-3HA) by PhaC (Fig.  1, reaction 5) . Although some of the point mutations have changed the number of substrates that FabH can interact with, the specific activities of these enzymes may still favor the utilization of the SCL substrates of C 4 over MCL substrates of C 6 to C 10 . Therefore, the SCL-MCL PHA copolymers produced by PhaC with FabH mutants have a higher mole percent of C 4 incorporated into the polymer.
A second factor that may determine the mole percent of monomer incorporated into PHA is the availability of the substrate. The main reaction of FabH is the condensation of malonyl-ACP with acetyl-CoA to form acetoacetyl-ACP, which is then used by the fatty acid biosynthesis pathway (Fig. 1,  reaction 1) . It had been shown previously that overproduction of wild-type FabH led to an accumulation of shorter-chain fatty acids in membrane phospholipids (33) . When producing PHA, overproduction of FabH may at first lead to a large increase in the acetoacetyl-ACP pool, which in turn could be converted to acetoacetyl-CoA and eventually to (R)-3-hydroxybutyrl-CoA via FabG. This substrate, in the presence of PHA synthase, could be converted to PHA. In the absence of PHA synthase, these compounds may be excreted from the cell. In either case, the enzymatic activity of the overproduced FabH would lead to a decrease in the concentration of substrates available for longer-chain fatty acid biosynthesis. Because a number of cycles of fatty acid biosynthesis would have to be completed before MCL substrates could be produced, the overproduction of FabH could limit the incorporation of MCL monomers of C 6 to C 10 into PHA because of the competition with itself to produce SCL substrates of C 4 length. Since incorporation of MCL monomers into PHA would require the overproduced mutant FabH proteins to intercept intermediates of fatty acid biosynthesis, such as 3-ketoacyl-ACP, FabH must also compete with the other enzymes of fatty acid biosynthesis for the substrate. This illustrates another possibility for the lower mole percent composition of MCL monomers of C 6 to C 10 in the SCL-MCL PHA copolymers in this study.
A third factor determining the PHA composition is likely to be the specificity of the PHA synthase. It has been shown that the A. caviae PhaC protein has specificity for (R)-3-hydroxyacyl-CoA substrates of C 4 to C 6 lengths (9). Although the Pseudomonas sp. strain 61-3 PhaC1 is capable of incorporating substrates of C 4 and C 6 lengths into a PHA polymer, it has a preferred specificity for substrates of C 8 to C 12 lengths (19, 21) . Based on the mole percent compositions of the polymers produced by the various strains shown in Tables 3 and 4 , it appears that all of the FabH proteins capable of producing monomers for PHA production do so with a specificity of C 4 Ͼ C 6 Ͼ C 8 Ͼ C 10 Ͼ C 12 . Therefore, the differences between the amounts of PHA accumulated in cells expressing the A. caviae phaC genes with the mutant fabH genes and the amount of PHA accumulated in cells expressing the Pseudomonas sp. strain 61-3 phaC1 gene with the mutant fabH genes shown in Tables  3 and 4 reflect the differences in the specific activities of the two PHA synthases, as well as the differences in the activities of the various mutant FabH proteins.
Saturation point mutagenesis at amino acid position 87 of FabH led to a broadening of substrate specificity and monomer-supplying capacity for PHA synthesis. In strains of E. coli overexpressing mutant fabH and PHA synthase (phaC) genes that could accumulate PHA, the point mutations at amino acid 87 have likely changed the binding-pocket size while leaving the transacylase function of the enzyme intact, thus accounting for the broadening of substrate specificity and the ability to provide monomers for SCL-MCL PHA production. However, in strains of E. coli overexpressing mutant fabH and phaC genes that failed to accumulate PHA, it is not known whether this resulted from the inactivation of the enzyme or from the lack of specificity of the PHA synthase for monomers produced by these enzymes. Previously, it was shown that M. tuberculosis FabH has specificity for substrates of C 8 to C 16 in vitro (4) . If the FabH mutants generated by this study created monomers with longer carbon backbones (more than C 12 ), they might fail to be incorporated into a growing PHA chain because of the specificities and limitations of the PHA synthases used in this study.
In previous studies, MCL PHA copolymer produced from glucose in E. coli consisted solely of MCL monomers with various yields (15, 25, 26) (Table 6 ). Furthermore, these studies had to use E. coli strains that were inhibited in the ␤-oxidation pathway in the cases where thioesterases were used as monomer-supplying enzymes, or they had to apply triclosan, an inhibitor of the fatty acid biosynthesis pathway, in order to generate MCL PHA from unrelated carbon sources. The present study used only JM109, a typical laboratory cloning strain of E. coli, to generate MCL PHA and is the first report to show that SCL-MCL PHA copolymer can be made in recombinant E. coli grown in the presence of glucose.
Although higher levels of SCL-MCL PHA production have been observed in native organisms with the inherent ability to produce SCL-MCL PHA, the molecular weights of the polymers accumulated were much lower (20) than those achieved in the present study. Because E. coli does not have a PHA depolymerase, the molecular weights of polymers produced in recombinant strains may be higher than those of polymers (18) . The molecular weights of microbially produced PHAs are important, since PHA polymer of high molecular weight has been shown to have improved mechanical properties (2). Glucose and related sugars are cheaper than fatty acids as a carbon source for PHA production, but sugars are comparable in price to plant oils, which can also be used as a carbon source for PHA production (10) . However, in order to use plant oils as a carbon source for PHA production, an intact ␤-oxidation pathway must be present within the host organism. The PHAproducing pathway presented here derives monomers from fatty acid biosynthesis rather than from the ␤-oxidation pathway and thus does not need to use strains with inhibited ␤-oxidation pathways or expensive inhibitors of fatty acid biosynthesis in order to produce SCL-MCL PHA copolymer. The ubiquity of fatty acid biosynthesis reactions in all organisms makes this new pathway highly desirable, as it may be possible to transfer the system to other organisms, such as photosynthetic organisms, to further reduce the costs of the carbon source. Studies of these possibilities are under way. In addition, because of the likely codependence between FabG and FabH necessary for monomer supply for PHA, studies are under way in our laboratory to determine whether coexpression of fabG and fabH would further change yields and/or compositions of PHAs in bacteria. Further mutagenesis studies of fatty acid biosynthesis and PHA synthase genes may allow us to precisely control the compositions of PHA copolymers and lead to commercial applicability for these microbially produced biodegradable polymers.
In conclusion, we have engineered a new pathway for SCL-MCL PHA copolymer accumulation from unrelated carbon sources in E. coli. By making subtle changes in the substratebinding pocket of FabH, we have been able to engineer new substrate specificities for the enzyme that result in different and specific monomer compositions of C 4 to C 10 for SCL-MCL PHA copolymers. Because FabH proteins from other bacterial species have substrate specificities different from those of E. coli FabH (3, 4, 11, 13) , they may be able to supply other monomers and different ratios of monomers for incorporation into PHA polymers produced in recombinant E. coli. It may be possible to modify the substrate specificities and activities of FabH via additional mutation. There are at least two other residues (Arg196 and Leu191) in the E. coli FabH protein besides F87 that may limit the size of the substrate-binding pocket, based on a comparison of the crystal structures of E. coli FabH and M. tuberculosis FabH (28) , and saturation point mutagenesis of these residues may lead to production of FabH enzymes with different monomer specificities and activities. The modified substrate specificities obtained from further mutation could result in PHA copolymers with monomer mole percent distributions different from those achieved in this study. Furthermore, if FabH enzymes with enhanced activities were generated by further mutation, it might be possible to produce recombinant strains capable of accumulating larger amounts of PHA.
